The global gelatin market is on a trajectory to reach USD 5.1 billion by 2028, with a notable compound annual growth rate (CAGR) of 6.6% during the forecast period leading up to 2023.
The pharmaceutical sector is expected to spearhead this expansion, experiencing the swiftest growth. The market’s upward trajectory is driven by surging demand for “free-from” food products, coupled with an escalating awareness of health among consumers. Notably, the rich protein content found in gelatin has triggered heightened demand from the nutraceutical and sports nutrition domains.
A pivotal component in this growth is the animal source segment, predicted to command the largest market share in 2023. Gelatin is predominantly derived from partial hydrolysis of collagen, sourced from diverse animals including marine life, mammals, poultry, and even insects. Commercial production predominantly hinges on bovine and porcine sources, although marine-derived gelatin occupies a smaller niche.
Europe is at the forefront of the gelatin market’s expansion, driven by health-conscious consumers who clamor for nutrient-rich and transparently labeled foods. The burgeoning pharmaceutical industry in the region further amplifies this growth. Evidently, key gelatin manufacturers like Gelita AG, PB Leiner, Trobas Gelatine B.V., and Lapi Gelatine S.P.A. are strategically positioned in Europe, leading to a flurry of product launches, collaborative ventures, and acquisitions aimed at meeting the escalating demands across the food, beverage, and pharmaceutical sectors.
Prominent market players include industry giants such as Darling Ingredients, Tessenderlo Group, Nitta Gelatin, Inc., Gelita AG, Weishardt, Lapi Gelatine Spa, India Gelatine & Chemicals Ltd., Trobas Gelatine B.V., Sterling, Roxlor, Suheung, and Ewald Gelatin GmbH.
